ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 374 filers reported holding ENCOMPASS HEALTH CORP in Q1 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $418,537 | +4.4% | 6,231 | +5.2% | 0.08% | +2.5% |
| Q2 2023 | $400,885 | +25.7% | 5,921 | +0.5% | 0.08% | +22.7% |
| Q1 2023 | $318,834 | +19.1% | 5,893 | +31.6% | 0.07% | +15.8% |
| Q4 2022 | $267,785 | +31.3% | 4,477 | +23.1% | 0.06% | +18.8% |
| Q2 2022 | $204,000 | -32.9% | 3,637 | -15.1% | 0.05% | -20.0% |
| Q1 2022 | $304,000 | +18.8% | 4,282 | +9.2% | 0.06% | +25.0% |
| Q4 2021 | $256,000 | -16.9% | 3,922 | -4.4% | 0.05% | -23.8% |
| Q3 2021 | $308,000 | +0.3% | 4,101 | +4.2% | 0.06% | 0.0% |
| Q2 2021 | $307,000 | -5.0% | 3,934 | -0.4% | 0.06% | -10.0% |
| Q1 2021 | $323,000 | +2.5% | 3,948 | +3.6% | 0.07% | -10.3% |
| Q4 2020 | $315,000 | – | 3,811 | +3.4% | 0.08% | – |
| Q3 2020 | $0 | -100.0% | 3,684 | +1.7% | 0.00% | -100.0% |
| Q2 2020 | $224,000 | 0.0% | 3,624 | +12.3% | 0.07% | +3.1% |
| Q4 2019 | $224,000 | – | 3,228 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Copeland Capital Management, LLC | 569,048 | $28,117,000 | 1.78% |
| Kalos Management, Inc. | 76,118 | $3,761,000 | 1.77% |
| Bridge City Capital, LLC | 30,231 | $1,494,000 | 1.08% |
| DALTON GREINER HARTMAN MAHER & CO | 331,823 | $16,395,000 | 0.86% |
| Horrell Capital Management, Inc. | 28,641 | $1,415,000 | 0.74% |
| Polianta Ltd | 26,600 | $1,314,000 | 0.43% |
| GLOBEFLEX CAPITAL L P | 30,177 | $1,491,000 | 0.42% |
| CARILLON TOWER ADVISERS, INC. | 768,748 | $37,984,000 | 0.40% |
| EAGLE ASSET MANAGEMENT INC | 1,070,271 | $53,001,000 | 0.29% |
| S. R. Schill & Associates | 8,108 | $401,000 | 0.25% |